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CHAPTER I
INTRODUCTION
Galactosyltransferases (GalTases) are a family of enzymes of estimated molecular
weights ranging from 29-130 kda (Magee et ai, 1973; Strous et al, 1986). Each
GalTase within this family exhibits specificity. This specificity has incurred many names
for GalTase where the prefixes P-1,4; P 1,3 or P 1,6 denote the types of bonds formed
between galactose and a substrate (Goudsmith et ai, 1989; Joziasse et al, 1992; Russo et
al, 1992; Teasdale et ai, 1992).
Russo et ai (1990) and Evans et ai (1993) have shown that the P-l,4-GalTase
gene specifies two mRNA transcripts of different lengths, a long transcript and a short
transcript. Both forms of the GalTase have identical large (358 amino acids) COOH
terminal catalytic domains, and identical single transmembrane domains. The only
difference in the primary structure between the two forms is that the long form contains
an NH2-terminal extension of 13 amino acids. These investigators also reported that the
long and short forms of the enzyme are differentially retained in the Golgi or directed to
the cell surface. Immunoelectron microscopy revealed that both the long and short forms
were restricted to the trans-Golgi compartment. It was found that when chimeric proteins
were constructed containing the NH2-terminal cytoplasmic and transmembrane domains
of GalTase, that the transmembrane portion was sufficient for Golgi retention (Nilsson,
1991; Russo et ai, 1992). Additionally, it was noted that a portion of the long form of
GalTase regulates and targets this form for trafficking to the
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cell surface where it functions as a cell receptor or adhesion molecule for extracellular
oligosaccharide ligands, facilitating cell-cell contact (Bayna et al, 1986, 1988; Russo et
al, 1990 and Zhou et al., 1998). Experimental evidence has been presented which
demonstrated that the 13 amino acid sequence unique to the long form of GalTase
overrides the Golgi retention signal and transports this protein out of the Golgi complex
to the cell surface. There it associates with the cytoskeleton and functions as a receptor
for extracellular oligosaccharide ligands on adjacent cell surfaces or in the extracellular
matrix during embryogenesis (Bayna et al, 1986, 1988; Evans et al, 1993; Nguyen,
1994; Elinton, 1995; Zhou et al, 1998).
Conventionally, GalTase has been viewed primarily as an intracellular enzyme
localized to the trans cistemae of the Golgi system in a membrane-bound form, and is
generally regarded as a marker enzyme for this organelle (Morre* et al, 1979, Strous et
al, 1982; Barker et al, 1972, Schachter et al, 1970; Cunningham, 1971). Figure 1-A
shows that within the Golgi complex GalTase catalyzes the transfer of galactose from
UDP-galactose (UDP-Gal) to terminal N-acetyl-glucosamine residues (Lopez et al,
1991).
The enzyme is also present in a soluble form in body fluids such as milk and
blood serum (Masri et al, 1988). In the lactating mammary gland, |3 1,4-GalTase has
been shown to interact with the hormonally regulatory protein alpha-lactalbumin (Figure
IB) to form the lactose synthetase complex (Brodbeck et al, 1967). This complex
(lactose synthetase) is responsible for the biosynthesis of the disaccharide lactose by
transferring galactose onto glucose (Brodbeck et al, 1967; Brew et al, 1967; Fitzgerald
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found associated with the plasma membrane of many cells and tissues where it is
believed to function as a receptor molecule in intercellular recognition and/or adhesion
during mammalian fertilization and development (Roseman, 1970; Shaper et al, 1985;
Lopez et al, 1985, 1988; Bayna et al, 1988; Penno et al, 1989, van Die et al, 1999,
Furukawa er a/., 1999).
The current investigator has chosen to examine some of the characteristics and
functional roles of rat plasma membrane GalTases that could possibly explain its role in
cell-cell contact. In order to address the issue of cell-cell contact in rat mammary plasma
membrane GalTases, the following objectives were established and pursued:
(I) To isolate and purify plasma membrane fractions from both normal and
physiologically altered (lactating) Long Evans rat mammary gland tissues.
(n) To assess the purity of the plasma membrane fractions via marker enzyme
assays, namely, alkaline p-nitro-phenyl phosphatase and succinate
dehydrogenase.
(EH) To validate the existence or non-existence of plasma membrane-associated
galactosyltransferases in both normal and transformed (lactating)
mammary gland tissues via Western Blot analysis.
(IV) To assess the relative molecular weight of the plasma
membrane-associated galactosyltransferases via Sodium Dodecyl
Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE).
(V) To conduct enzymatic studies on plasma membrane fractions obtained
from both tissue types by comparing the efficiency of the plasma
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membrane-associated GalTase in the transfer of [^H]-galactose onto the
protein acceptor, ovomucoid.
Rationale
It has been demonstrated that cell surface Galactosyltransferase functions in
cell-cell contact by binding to complementary oligosaccharide substrates on adjacent cell
surfaces or in the extracellular matrix. The purpose of this study was to determine the
existence or non-existence of plasma membrane-associated galactosyltransferase(s) in
both normal and physiologically altered (lactating) Long Evans rat mammary gland
tissues via biochemical and immunohistochemical analysis.
It has been shown that metabolic conditions of an individual animal or human
may significantly influence the mammary gland’s response to hormones. The response
of the mammary gland to hormonal and metabolic interactions results in developmental
changes that modify both the architecture and biological characteristics of the gland. The
mammary gland, in turn, responds selectively to given hormonal stimuli, depending upon
specific topographical differences in gland development, which modulates the expression
of either cell proliferation or differentiation. In this study physiologically altered
(lactating) mammary gland tissue was utilized, since this tissue follows a pattern of
metabolic amplification (Figure 2), which mammary tumors mimic during the
carcinogenesis process. The generated results allow for the proposal of a plausible
cell-cell contact model. As such, the plasma membrane-associated form of GalTase,
which is putatively involved in initiating cell-cell contact, was identified.
The proposed model (Figure 3) illustrates the profiles of both normal
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(non-lactating) and physiologically altered (lactating) mammary gland cells. It is
proposed that during the process of mammogenesis and lactation, the cells of the
mammary gland are stimulated to proliferate and ultimately begin the process of
lactogenesis, thus, elevating the concentrations of both intracellular and plasma
membrane-associated GalTases (Mitchell et ah, 1990; Strous et ah, 1986).
This model demonstrates that the increased concentrations of plasma membrane-
associated GalTases are essential for the process of mammogenesis to proceed. Soon
after weaning of the newborn the mammary gland returns to an inactive state and,
because milk is no longer synthesized and removed, the hormones (prolactin and
oxytocin) are no longer stimulated to be released. Thereafter, the secretory activity of the
lactogenic epithelium begins to decrease. Any remaining dormant milk subsequently
increases intra-mammary pressure, and leads to alveolar rupture. The retained secretory
products are then phagocytosed (Bland et ah, 1991), the lobular structure atropies and the
secretory cells degenerate (Figure 2). This system represents a model as to how the
process of tumorigenesis may proceed. The lactating mammary gland demonstrates




Figure 2. Diagram of the cycle of secretory cells of the mammary gland from
the resting phase to secretion and return to the resting phase.
Adapted from Lawrence (1985).
Insulin and growth hormone stimulate the biosynthesis of milk. Prolactin
synergizes the insulin effect to stimulate the cells to secretory activity. As
secretion commences, the enlarged cells with their thickened apical
membrane become cuboidal, changing to a cylindrical shape just before
milk secretion. The tip pinches off, leaving the cell intact. The proteins,
lipids and lactose are then released in the secreted solution via apocrine
and merocrine mechanisms. At the completion of this secretory cycle the
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Figure 3. Mammary gland cell-cell contact model.
Diagrammatic representations of cell-cell contact in both normal (A) an
lactating (B) mammary gland cells. The model proposes that cell surface
galactosyltransferase (GalTase) initiates the process of cell-cell contact by
binding to its substrate located on the opposing cell. The figure illustrates
that the relative concentration of GalTase present on the surface of the
physiologically altered cells is drastically increased over that of the normal
mammary gland cells.
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A. Normal Mammary Gland Cells
B. Physiologically Altered (Lactating) Mammary Gland Cells
CHAPTER II
LITERATURE REVIEW
Galactosvltransferase; Synthesis, translocation, and in situ function
(31,4 galactosyltransferase (GalTase) is a member of a functional family of
enzymes termed glycosyltransferases. It has been estimated that there are at least 100
different membrane-bound enzymes, such as GalTase, that participate in the coordinated
biosynthesis of diverse carbohydrate side chains found on glycoproteins and glycolipids.
Structural characterization and subsequent comparison of these enzymes have been
hampered by their low cellular abundance (Bayna et al, 1986, Goudsmith et al, 1989,
Russo et al, 1990, 1992; Joziasse et al, 1992; Teasdale et al., 1992, Zhou et al, 1998).
Membrane-bound pi,4-galactosyltransferase (GalTase) is normally localized in
intracellular membranes, such as the endoplasmic reticulum and Golgi complex, where it
participates in the synthesis of glycoconjugates for secretion and transport to the cell
surface (Schachter et al, 1980; Strous et al, 1983). GalTase has also been localized both
on the cell surface as well as intracellular membranes, where it functions in intracellular
adhesion. On the cell surface it functions as a receptor for oligosaccharide ligands on
opposing cells or in the extracellular matrix during mammalian fertilization and
development (Pestalozzi et al, 1982; Strous et al, 1983; Shur, 1988; Youakim et al,
1994; Evans et al, 1993; Larson et al, 1997; Akimoto et al, 1995; Huszar et al, 1997;
Johnson et al, 1999).
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Nearly all proteins destined for secretion, and a majority of those destined to
become membrane proteins, have carbohydrates attached to them. Glycosylation, or the
addition of carbohydrate, begins prior to the completion of the polypeptide chain.
Nascent polypeptides are synthesized and ejected into the lumen of the rough
endoplasmic reticulum (Figure 4). Core oligosaccharides are attached to asparagine
residues, as they appear on the lumenal side of the membrane (Fleischer, 1983). There
appear to be two mechanisms of glycosylation in eukaryotes, one of which adds sugars to
the protein one monosaccharide at a time, and the other which assembles a complete or
nearly complete carbohydrate chain on an intermediate carrier (either on a natural vitamin
A, retinol, or on another class of lipids called dolichols) and then transfers the
oligosaccharide to the protein (Figure 4). It is believed that secretory proteins are
glycosylated primarily by the first mechanism, while membrane proteins are more apt to
be glycosylated by the second, or carrier method (Blobel et al, 1975; Cardell, 1977;
Depierre et al, 1975; Lennarz, 1975; Molnar, 1975; Parodi et al, 1976).
The core oligosaccharide is composed of three glucose, nine mannose, and two N-
acetyl-glucosamine (GlcNAc) residues (Figure 4). Subsequently, the outer glucose
residues and three or four of the nine mannose residues may be trimmed from the
oligosaccharide by enzymes that are present in the lumen of the endoplasmic reticulum.
The glucose residues are removed by glucosidases I and II, often prior to the completion
of the polypeptide chain. The mannose residues are removed by an ER a-mannosidase




Figure 4. Diagram outlining some of the steps in the assembly and processing of
N- and O-Iinked oligosaccharide chains on glycoproteins. Adapted
from Fleischer (1983).
1. Dolicol phosphate (Dol-P) with one phosphate.
2. Dolicol phosphate with its attached core oligosaccharide (14 6-C
sugars).
3. A nacent polypeptide chain.
4. Core oligosaccharide is transferred to an asparagine (Asn) residue.
5. Before the termination of polypeptide synthesis the three glucose
(G) residues are trimmed off.
6. Glycoprotein is translocated from the rough endoplasmic reticulum
through the cis Golgi Network to the cis Golgi.
7. By the time the glycoprotein reaches the medial Golgi, trimming
plus the addition of sugars leaves N-acetylglucosamines (Gn) as
terminal sugars.
8. In the trans Golgi, Golgi associated GalTase catalyzes the addition




Enzymes responsible for the stepwise addition of sugars to the proteins, and thus
responsible for the first glycosylation method, are present in the cistemae of the rough
endoplasmic reticulum where they are available to the proteins as they appear across the
membrane. Proteins glycosylated in this way probably cannot become incorporated into
membranes because their new sugar coating provides a relatively polar surface that
makes them soluble in water and keeps them away from the lipid membrane. They will,
thus, remain enclosed by membranes until they are discharged from the cell (Blobel et
al, 1975; Cardell et al, 1977; Depierre et al, 1975; Lennarz, 1975; Molnar, 1975; Parodi
et al., 1976).
In contrast, membrane proteins, (i.e., proteins that actually become part of some
membrane) must be amphipathic with a dominant hydrophobic domain even if they have
carbohydrates (which are polar and, therefore, hydrophilic) attached. These proteins may
incorporate themselves into the membranes of the rough endoplasmic reticulum as the
proteins are being formed, rather than becoming enclosed by the endoplasmic reticulum.
Newly synthesized polypeptides leave the “rough” endoplasmic reticulum and are
incorporated into vesicles budding from the transitional elements of the endoplasmic
reticulum in an energy-dependent manner. After leaving the “rough” endoplasmic
reticulum, the vesicular carriers fuse with the cw-Golgi elements. Many studies have
shown that the Golgi complex is the site where proteins are selected for movement to
secretory storage granules, lysosomes, or to the plasma membrane via the constitutive




It has been shown that the bovine and murine p 1,4-GalTase gene is unique in that
it specifies two mRNA transcripts of different lengths, a “long” transcript and a “short”
transcript. Both forms of the GalTase have identical large (358 amino acids)
COOH-terminal catalytic domains, and identical single transmembrane domains (Russo
et al., 1990; Strous et al, 1986; Mengle-Gaw et al, 1991; Shaper et al, 1990; Rajput et
ai, 1996; Lopez, 1991). The gene specifies two mRNAs of 4.1 and 3.9 kilobases, as a
consequence of initiation at two different AUG start sites. The start sites are
approximately 200 base pairs apart (Rajput et ai, 1996). The only difference in the
primary structure between the two forms is that the “long” form contains an
NH2-terminal extension of 13 amino acids.
It has been reported by Russo et al. (1990) that the “long” and “short” forms of
the enzyme are differentially retained in the Golgi or directed to the cell surface.
Experimental evidence has been presented which demonstrates that the 13 amino acid
sequence unique to the “long” form of GalTase overrides the Golgi retention signal and
transports this protein out of the Golgi complex to the cell surface where it associates
with the cytoskeleton and function as a receptor for extracellular oligosaccharide ligands
on adjacent cell surfaces or in the extracellular matrix (Bayna et ai, 1986, 1988; Evans et
ai, 1993; Nguyen, 1994; Hinton, 1995).
“Short” GalTase Function and Localization
The “short” form of GalTase is primarily localized within the tranj'-cistemae of
the Golgi complex. It functions in the biosynthesis of N-linked oligosaccharide chains by
catalyzing the transfer of galactose, from UDP-Gal, to the acceptor sugar.
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A^-acetylglucosamine, forming pi,4-lactosamine (Russo et al, 1990). In the lactating
mammary gland, GalTase, in the presence of a-lactalbumin (Protein B), is involved in
the biosynthesis of the disaccharide lactose (milk sugar). Brodbeck et al. (1966) and
Brew et al.. (1967) isolated and identified Protein B from milk and investigated it’s role
in lactose synthesis. It was found that in its purest form a-lactalbumin has a crystalline
structure and acts as the co-factor for GalTase (Protein A) during the catalytic activities
involved in the synthesis of lactose. It was also found that Protein A catalyzes the
biosynthesis of N-acetyllactosamine independent of a-lactalbumin.
Experimental evidence has been presented which has shown that a short
NH2-terminal fragment that includes the cytoplasmic and transmembrane domain
specifies Golgi retention (Russo et al., 1992). Chimeric proteins containing the
NHa-terminal cytoplasmic and transmembrane domains were fused to the cytoplasmic
protein pyruvate kinase. The chimeric proteins were then stably expressed in Chinese
hamster ovary cells. The proteins expressed from the construct were localized by
immunofluoresence staining to a perinuclear region, identified as the Golgi by
co-localization with wheat germ agglutinin. Immunoelectron microscopy revealed that
the “short” GalTase was restricted to the rran^-Golgi compartment (Russo et al., 1992).
Teasdale et al.. (1992) also demonstrated that the transmembrane domain of bovine
GalTase contains a positive Golgi retention signal. Bovine GalTase was characterized in
transfected cells with anti-bovine GalTase antibodies. The antibodies recognized native
bovine GalTase and showed minimum cross-reactivity with GalTase from non-bovine
sources.
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“Short” GalTase and Lactation
During pregnancy, the mammary gland undergoes final maturation in preparation
for lactation (Figure 2). During this process, called mammogenesis (Mitchell and Bassett,
1990) the development and function of the mammary gland is stimulated by a variety of
hormones including the sex steroids, prolactin, oxytocin, cortisol, thyroid hormone, and
growth hormone (Figure 5). The trophic effects of the reproductive hormones: estrogen,
progesterone, and prolactin are most important in normal breast development and
function.
Estrogen has potential mitotic effects on the mammary epithelium and initiates
ductal development. It also increases the number of estrogen and progesterone receptors
on epithelial cells. Progesterone is responsible for differentiation of the epithelial cells
and causes lobular development. Prolactin contributes to the development of adipose
tissue and is required, with the presence of growth hormone and cortisol, for the growth
and development of the mammary epithelium. It increases the number of estrogen
receptors and epithelial cells and acts synergistically with estrogen in ductal development
and progesterone in lobuloalveolar development.
Additionally, prolactin stimulates differentiation of the milk-producing cells of
the breast and synthesis of the components of milk (Bland and Copeland, 1991). These
highly vascularized secretory cells (Figure 2) extract water, lactose, amino acids, fats,
vitamins, minerals, and numerous other substances from the mother’s blood, converting
them into milk for the newborn. Stores of adipose tissue laid down during pregnancy are
drawn upon to provide substrate for milk synthesis (Riordan and Auerbach, 1993). Most
proteins in milk (e.g. casein, a-lactalbumin, and P-lactoglobin) are formed from free
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Figure 5. Overview of the neuroendocrine control of breast development and
function with relationship to gonadotropic hormones of the anterior
pituitary and ovary.
Basophil secretion of luteinizing hormone (LH) and follicle-stimulating
hormone (FSH) is responsible for ovarian synthesis and release of
progesterone and estrogen, respectively. The mammotropic effects of
estrogen and progestin initiate myoepithelial and alveolar development.
Ductal and stromal enlargement with pregnancy occur as a result of
progestin and estrogen secretion in excess from the corpus luteum and
thereafter from the placenta. Acidophil cell secretion of prolactin (PRL) is
initiated following evacuation of the gravid uterus and is mammotropic to
the lobular alveoli. The suckling reflex initiates oxytocin release from the
posterior pituitary and is stimulatory to alveolar myoepithelial cells to
initiate milk release. Neuroendocrine organs other than the pituitary and
ovary secrete hormones (glucocorticoid, growth hormone, insulin,
throxine) that are tropic to ductal and glandular maintenance and growth
(Bland and Copeland, 1991).
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amino acids in the secretory cells of the mammary gland.
The formation of these proteins as well as mammary enzymes is induced by
prolactin and further stimulated by insulin and cortisol. One enzyme of particular interest
is the “short” form of galactosyltransferase (Lawerence, 1985). As stated earlier, this
form of GalTase functions in the biosynthesis of the disaccharide lactose, in the presence
of the hormonally regulatory protein a-lactalbumin (Figure IB). After delivery of the
newborn, a complex neuroendocrine feedback system controls milk ejection and
maintains lactation until weaning. Figure 2 shows that involution follows, with a gradual
return to the resting state, until pregnancy again stimulates a cycle of secretory activity
(Mitchell and Bassett, 1990).
“Long” GalTase Function and Localization
Pl,4-galactosyltransferase has been localized to the cell surface of many cells and tissues
where it is believed to function as a receptor molecule in intercellular recognition and
adhesion (Roseman, 1970; Shaper et ai, 1985; Lopez, 1985, Bayna et ai, 1986, 1988;
Penno et ai, 1989; Evans et ai, 1993; Johnson et ai, 1999). Biochemical and
immunocytochemical studies have demonstrated that GalTase is present on the surface of
the plasma membrane (Roth et ai, 1985; Shur, 1982; Lopez, 1985; Barcellos-Hoff, 1992,
Appeddu et ai, 1994; Bayna et al, 1986; Nguyen, 1994; Browne et ai, 1997). Plasma
membrane surface GalTase has been identified in embryonal carcinoma cells, sea urchin
sperm, Xenopus laevis sperm, as well as mouse sperm cells which contain no detectable
intracellular GalTase enzymatic activity (Lopez et ai, 1985; 1987, Tian, 1997; 1999,
Hirohashi, 1998, 1998; Kitazume-Kawaguchi, 1997; Just, 1997). The localization of
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GalTase to the surface of mouse sperm cells (Lopez et ai, 1987; Pratt et al, 1993;
Youakim et ai, 1994; Gong et ai, 1995; Shur et ai, 1998; Lu et al, 1997; Huszar et al,
1997; Johnson et al, 1999) has led investigators to propose that it plays a role in
intercellular recognition and adhesion.
Evans et al. (1993) and Johnson et al. (1999) have stated that recent advances in
the molecular biology of GalTase have demonstrated that altering the expression of
surface GalTase has direct effects on cell adhesion and migration. Experimental
evidence presented by Nguyen et al. (1994) demonstrated the role of plasma membrane
bound GalTase. It was shown that HeLa cells, which normally express negligible levels
of surface galactosyltransferase, were utilized to produce a cell surface GalTase
dependent phenotype. It was found that those HeLa cells, which were stably transfected
with the murine ^ 1,4-galactosyltransferase gene, exhibited increased cell spreading.
Antibody inhibition studies confirmed that the surface-localized GalTase was responsible
for the increased cell-spreading characteristics of the transfected cells. The
aforementioned studies present further evidence that plasma membrane-associated





Female Long Evans strain rats averaging 250-300 gm were obtained from Charles
River Laboratories (Wilmington, MA). The animals were housed in the animal facilities
of Morehouse School of Medicine and bedded on sterile wood shavings. They were
provided water and standard Purina rat laboratory chow ad libitum,.
Chemicals
Chemicals and radiochemicals used in these studies were obtained from the
following companies: UDP[^H]-galactose; sp. act. 250 |J,Ci/mmol (Dupont, New England
Nuclear Company; Boston, MA); 200 proof ethanol (Aaper Alcohol and Chemical
Company; Shelbyville, KT); N-N’-methylene-bis-acrylamide, acrylamide, ammonium
persulfate, dithiothreitol (DTT), ethylene diamine tetra-acetate (EDTA) (United States
Biochemical Corporation; Cleveland, OH); methyl alcohol (Aldrich Chemical Company;
Milwaukee, WI). All other chemicals were of the highest grade possible and were
purchased from Fisher Scientific Company (Norcross, GA), and Sigma Chemical




Isolation of Mammary Gland Plasma Membrane
Lactating and non-lactating mammary gland tissue samples were dissected from
freshly sacrificed rats (Figure 6). The tissue was immediately placed in liquid nitrogen
until further processing on the same day. The tissue was then thawed, weighed, and
subjected to differential centrifugation to obtain plasma membrane, cytosol,
mitochondrial and nuclear fractions following a modified method of Ray (1970) and
Femandez-Briera et al. (1989). All operations were conducted at 0-4°C.
Approximately 10 gm of mammary gland tissue was minced in 50 ml of 0.25 M
cold sucrose phosphate buffer to very fine pieces. This minced mammary gland
specimen was placed in an Omnimixer (Fisher Scientific, Pittsburgh, PA) in buffer and
vortexed at 35 rpm for 2 min (repeated 6 times), after which it was then homogenized
with 6 strokes in a Potter-elvehjen homogenizer fitted with a Thomas teflon pestle
(Thomas Scientific; Swedesboro, NJ). The homogenate was finally filtered through 9
layers of cheese cloth and then centrifuged at 15,000 rpm at 4°C in a preparative
centrifuge (model J2-21, JA-20 rotor, Beckman, Fullerton, CA) for 30 min. The
supernatant was saved and stored at -20°C as the cytosol fraction.
The pellet was resuspended in 25 ml of 0.25 M sucrose, 50 mM triethanolamine,
50 mM potassium chloride, 5 mM magnesium chloride buffer (STKM buffer) and
homogenized with 4 strokes. The homogenate was then centrifuged at 15,000 rpm for 30
min (repeated twice) and the supernatant collected each time as the cytosol fraction. The
final homogenate was centrifuged at 25,000 rpm for 7.5 min at 4°C in an L8-70
ultracentrifuge (Beckman, Fullerton, CA), using a T-40 rotor. The supernatant was kept
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Figure 6. Dissection photographs illustrating the anatomy of the Long Evans
Rat mammary gland.
A. Physiologically altered (Lactating) Mammary Galand tissue. B. Normal
(Non-Lactating) Mammary Gland Tissue (Arrows). (Photographs





and combined with first supernatant as the cytosol fraction, and the pellet resuspended in
12 ml of 57% sucrose TKM buffer, vortexed, and homogenized with 4 strokes. Four
(4.0) ml of this homogenate was placed in a cellulose nitrate ultracentrifuge tube (for
S.W.40 Ti rotor). Four (4.0) ml of 37.2% sucrose TKM buffer was carefully layered
above each sample followed by 0.25 M sucrose TKM buffer added above the second
layer until the tube was full. These tubes were then centrifuged at 25,000 rpm at 0°C for
16-18 hours in a ultracentrifuge (model L8-70, S.W. 40 Ti rotor, Beckman, Fullerton,
CA). After centrifugation each fraction (Figure 7) designated as FI, F2, F3, F4 was
collected and centrifuged at 40,000 rpm in a ultracentrifuge (Beckman, Fullerton, CA),
model L8-70 (T-40 rotor) for 30 min. The supernatant was carefully aspirated and the
pellet of each fraction was resuspended in 1.0 ml of 0.25 M sucrose TKdVI buffer.
The cytosol fractions are the combination of all supernatants discussed above.
The fractions were collected and stored in liquid nitrogen. Aliquots of isolated fractions
were prepared for protein concentration determination, SDS-PAGE, as well as qualitative
enzyme assays to monitor for fraction purity.
Assessment of Plasma Membrane Fraction Purity
Protein concentrations and purity of the plasma membrane fraction were
determined via marker enzyme analyses, as described below.
Protein Measurements
Eight hundred micro-liters (800 p.1) of standards (known quantities of Bovine
Serum Albumin) and diluted samples were placed in test tubes. Two hundred microliters
(200 p.1) of BioRad’s dye reagent concentrate were then added, yielding a volume of 1
ml. The mixture was incubated for a period of 15 minutes at room temperature, after
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which the OD 595 versus the reagent blank was determined using a Beckman DU-640
Spectrophotometer (Beckman, Fullerton, CA). A standard plot of OD595 versus




The activity of alkaline p-nitrophenyl phophatase (a plasma membrane marker
enzyme) was assayed by the spectrophotometric procedures of Fleischer (1983). The
formation of p-nitrophenol from p-nitrophenyl phosphate was determined
spectrophotometrically in a 2 ml reaction mixture containing one part substrate solution
[10 mM sodium thymidine 5’-monophosphate, p-nitrophenyl ester (Sigma Chemical Co.;
St. Louis, MO)], one part Tris-HCl buffer (pH 9.0), and two parts water. The mixture
was warmed to 37°C. In a chilled 12 x 75 mm test tube, a sample of the plasma
membrane fraction was diluted to 0.1ml with 0.25 M sucrose. The reaction mixture (0.4
ml) was added to the test tubes and incubated at 37°C for 2 hours. A background/blank
(without enzyme) was prepared and incubated under the same condition as the samples.
The formation of p-nitrophenol was monitored at 410 nm in a spectrophotometer (DU
650, Beckman, Fullerton, CA) and the blank value subtracted from the sample value.
Enzyme activity was expressed as absorbance units/min/mg protein.
Succinate Dehydrogenase
The activity of succinate dehydrogenase on the inner mitochondrial membrane
was determined by a modified method of Fleischer (1983). The transfer of hydrogen to
2, 3, 5-triphenyl-2H tetrazolium chloride (TTC) was monitored in a 3 ml reaction
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containing 100 mM potassium phosphate buffer at pH 7.5, 3 mM phenazine methosulfate
(PMS), 60 mM sodium succinate, 0.9 ml distilled water, 30 mM 2, 3, 5-triphenyl-2H
tetrazolium chloride and 10 pg of protein. Sample tubes were prepared and the plasma
membrane fraction was added to the sample tube last. Timing began immediately after all
of the components were added to the tube. All sample tubes were run against a common
blank containing all components except the enzyme extract. The reaction tubes were then
incubated in a water bath at 38*^C for 20 minutes, after which, 7 ml of acetone were added
to each tube to stop the reactions. Each tube was then centrifuged for 5 minutes at 3,000
rpm. A portion of the supernatants was poured off into colorimeter tubes for reading at
490 nm.
Characterization of Plasma Membrane-Associated Galactosvltransferase
Plasma Membrane-Associated P-1.4-Galactosvltransferase Activity Assay
Galactosyltransferase activity in reaction mixtures with the endogenous acceptor
protein, ovomucoid, was assayed according to a modified method of Femandez-Briera et
al. (1989). A fresh batch of the assay mixture was prepared prior to conducting the
assay. The assay mixture consisted of: 200 pi sodium cacodylate, 200 pi ovomucoid, 6
pi P-mercaptoethanol, 40 pi UDP-galactose, 40 pi Triton X-100, 20 pi ATP, 40 pi
MnCla, 10 pi [^H]-UDP-galactose, and 1040 pi of water.
The plasma membrane preparation was diluted 1:20 with distilled water.
Subsequently, 80 pi of assay mixture was added to screw-capped Eppendorf tubes
containing duplicate 20 pi aliquots of the diluted samples and of water (blanks). The
samples were then vortex and incubated at 37°C for exactly 30 min. The reaction was
then stopped by adding 1 ml of ice-cold phosphotungstic acid/hydrochloric acid
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(PTA/HCl) and centrifuged at 14,000 rpm on a bench-top centrifuge for 7 sec. The
supernatants were aspirated from the solution and discarded, and 1 ml of PTA/HCl was
then added to the pellets. The pellets were resuspended by vortexing or scraping and
centrifuged again. The supernatant was then aspirated from the solution and discarded.
One milliliter of ice-cold 95% ethanol was added, and the pellets were resuspended. The
tubes were then centrifuged again and the supernatant was removed. Fifty (50) |xl of 2 M
Tris were added followed by 200 pi of 5% SDS. The mixture was shaken or vortexed
until dissolved. The tubes were not scraped in order to avoid excessive frothing. Finally,
ten (10) pi of assay mixture, 40 pi of water, and 200 pi of 5% SDS were added to a fresh
tube to allow determination of the [^H]-UDP-galactose specific activity in the mixture.
One (1) milliliter of scintillation fluid was then added to each sample and the tubes were
then vortexed and counted in a scintillation counter using the tritium channel.
GalTase Calculations1.A protein standard curve was constructed by plotting the absorbance of each standard
against the amount of BSA it contained. The slope (m) and the intercept at the
ordinate axis (c) was calculated. The protein concentrations of the samples was
calculated as follows:
(sampleabsorbance - c)x dilution
Protein concentration (mg/ml) =2.The specific activity (SA) of [^HJUDP-galactose in the assay mixture was calculated
as follows:
d [dpm of standard-blank)SA [ H]UDP-galactose (dpm/nmol) = .3.The concentration of galactosyltransferase in each sample was calculated as follows:
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Concentration GalTase (nmol/hr/ml) = blank)x2000
SA [ ^H\UDP - galactose
4. The specific activity (SA) of GalTase was calculated by dividing its concentration by
the protein concentration of the same sample to give SA in nmol/hr/mg protein.
Sodium Dodecvl-Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
The isolated plasma membrane fractions from both the normal and
physiologically altered (lactating) mammary gland tissue were processed and subjected to
SDS-PAGE according to the method of Laemmli (1970). Twelve percent (12%) sodium
dodecyl-sulfate (SDS) polyacrylamide gels were used. Twenty ml of 30% acrylamide/bis
(Sigma Chem. Co., St. Louis, MO) solution, 12.0 ml of 2.0 M Tris-HCl buffer (pH 8.8),
0.5 ml of 10% SDS (Sigma Chem. Co., St. Louis, MO) solution, 7.0 ml of 60% sucrose
solution, and 10.0 ml of distilled water were mixed in a beaker (under the hood). Two
hundred-fifty pi of newly prepared 10% ammonium persulfate (APS, Sigma Chem. Co.,
St. Louis, MO) and 25 pi of N, N, N’, N’-tetramethylethylenediamine (TEMD, Sigma
Chem. Co., St. Louis, MO) were added to this solution and mixed thoroughly. This
mixture was poured into a gel casting unit and allowed to polymerize for about 20-30
min.
For gel loading, a 1 to 1 dilution of sample protein to BEST-DS solution
(bromophenol blue; 0.02%, EDTA; 4 mM, sucrose 34%, Tris base; 80 mM,
dithiothreitol; 10 mM, SDS; 4%) was mixed and boiled in a water bath (Precision
Scientific, Winchester, VA) for two min. The mixed samples were then cooled and
loaded into each well of the Mini-PROTEAN Il-i Cell gel apparatus (BIO-RAD
Laboratories, Hercules, CA). The power supply (FB-135, Fisher Biothech
electrophoresis power supply systems, Pittsburgh, PA) current of 175 volts was fixed for
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the running time (about 45 minutes). Kaleidoscope prestained low molecular weight
marker proteins (BIO-RAD Laboratories, Hercules, CA) which include: myosin 209,000
daltons; beta-galactosidase 130,000 daltons; bovine serum albumin 85,000 daltons;
carbonic anhydrase 43,000; soybean trypsin inhibitor 32,000 daltons were used.
After the bromophenol blue tracking dye reached the bottom of the gel, the gel
was carefully removed from the gel apparatus and processed for Western Blot analysis.
Western Blot Analysis
A portion of the protein solution was mixed with the sample buffer. The final
sample conditions were 2% SDS, 100 mM DTT, 60 mM Tris (pH 6.8), and 0.01%
bromophenol blue. The total amount of protein did not exceed 30 pg/mm of loading
surface (150 p.g/5 x 1mm slot). For individual bands, loading more that 0.3 pg/mm^ of
loading surface (1.5 pg/5 x 1 mm slot) lead to distortion. The Mini-PROTEAN II
electrophoresis cell (BIO-RAD, Hercules, CA) was used for this gel electrophoresis
because transfer was faster and more complete from thinner gels. The separated
polypeptides were then transferred to a membrane support.
Transfer Procedure
One sheet of nitrocellulose paper and four sheets of absorbent filter paper were
cut to the size of the gel. The nitrocellulose membrane was first soaked in distilled water,
and allowed to become water saturated by capillary action from the bottom (several
minutes), then it was submerged for 2 minutes. The gel, membrane, absorbent filter
papers, and support pads were then immersed in transfer buffer for 5 minutes to ensure
they were thoroughly soaked. Care was taken to exclude air bubbles from the support
pads. The transfer sandwich was then assembled, keeping all components wet, and
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making sure that the sandwich was tightly assembled. The complete sandwich was
placed in the transfer tank with the membrane closest to the positive electrode (anode, red
electrode). The proteins were then transferred at 100 volts for 45 minutes for proteins
under 100,000 mw on a 15 x 15 x 0.1 cm gel. The nitrocellulose blot was then washed
several times with Tris Buffered Saline (TBS). The TBS was then replaced with the
Blotto/Tween blocking solution and incubated at room temperature with agitation for
approximately 1 hour. The nitrocellulose was then ready for the addition of the primary
antibody. The blot was removed from the blocking solution and washed twice for 5
minutes in TBS. The primary antibody solution was then added at a volume of 10 ml per
15 X 15-cm blot. It was then incubated with the primary antibody for at least 1 hour at
room temperature with agitation. After the 1 hour incubation the blot was washed with 4
changes of TBS for 5 minutes each. Immediately following the washes the labeled
secondary antibody solution was added at a concentration of 1 mg/ml. It wds then
incubated again for approximately one (1) hour at room temperature and agitation. The
membrane was then washed with 4 changes of TBS for 5 minutes each. The blot was then
ready for detection.
Detection procedure
The ECL + Plus Western blotting detection system was utilized to detect the
antigen. After the last wash, the nitrocellulose was drained by placing it on a piece of
absorbent paper for a few minutes. The membrane was then soaked briefly in the
detection reagent. This elicited a peroxidase-catalyzed oxidation of luminol and
subsquently enhanced chemiluminescence, where the Horseradish Peroxidase (HRP)
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labeled protein was bound to the antigen on the membrane. The resulting light was
detected on film in minutes, or even seconds.
CHAPTER IV
EXPERIMENTAL RESULTS
Isolation of Plasma Membrane Fractions
The characterization of plasma membrane-associated GalTase(s) required a
plasma membrane preparation free of rough and smooth endoplasmic reticulum,
mitochondria, and especially Golgi membranes (Ray, 1970, Femandez-Briera et al,
1989, George-Taylor, 1994). Table 1 illustrates that other mammalian subcellular
components have very similar pelleting forces and equilibrium density in sucrose-H20
gradients. Therefore, in the current studies protocols that yielded minimal levels of cross
contamination were exploited.
Determination of Plasma Membrane Fraction Purity
The isolation technique utilized to obtain plasma membranes from mammary
gland tissues yielded fractions with protein concentrations of 282.82 mg/g for normal
(non- lactating) and 2055.59 mg/g for physiologically altered (lactating) tissue. As shown
in figures 8 and 9, this fraction also exhibited a great enrichment in alkaline p-nitrophenyl
phosphatase, a marker enzyme for plasma membrane, and minimal contamination by
inner mitochondrial membranes, as evidenced by the low level of mitochondrial marker
enzyme activity, succinate dehydrogenase.
Characterization of Plasma Membrane-Associated Galactosvltransferase




Optimum enzyme activity was obtained at 37°C and pH 7.5. Figure 10 shows the
activity of both the normal (non-lactating) and physiologically altered (lactating)
mammary gland plasma membrane-associated GalTase towards the endogenous acceptor
protein ovomucoid. The data demonstrated that the normal plasma membrane-associated
GalTase had a higher activity than that of the physiologically altered (lactating) plasma
membrane-associated GalTase. The relative concentrations of GalTase within the various
reaction tubes throughout the incubation period are shown in figure 11.








and Vesicles 1 X 10^-1 X 10^ 1.12- 1.18
Inner Mitochondrial
Membrane 1 X 10^ 1.26-1 .41
Outer Mitochondrial
Membrane 1 X 10^ 0.84 - 0.96
Rough Endoplasmic
Reticulum 3 X 10*^ 1.15-1.25
Smooth Endoplasmic
Reticulum 1 X 10^ 1.10-1.20
Golgi Membrane 1 X 10^ 1.12-1.14
Lysosomes 4x 10^ 1.20-1.22
Data was obtained from Fleischer (1983). These values are for fractions obtained from
liver tissue. This table gives an approximate range of sedimentation forces and
equilibrium densities within which the bulk of the components are distributed.
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Figure 8. Alkaline p-Nitrophenyl Phosphatase Assay.
Reaction mixtures contained 10 mM sodium thymidine
5’-monophosphate, p-nitrophenyl ester, 0.25 M sucrose, 0.1 M Tris-HCL
(pH 9.0), 0.5 M glycine, 0.5 M Na2C03, and 10 |xg of protein.
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Figure 9. Succinate Dehydrogenase Assay.
Reaction mixture contained 100 mM potassium phosphate (pH 7.5),3 mM
phenazine methosulfate (PMS), 60 mM sodium succinate, 0.9 ml distilled















Figure 10. Specific Activity of Plasma Membrane-Associated
galactosyltransferase(s).
The assay mixture consisted of: 200 pi sodium cacodylate, 200 pi
ovomucoid, 6 pi P-mercaptoethanol, 40 pi UDP-galactose, 40 ml Triton
X-100, 20 pi ATP, 40 pi MnCb, 10 pi [^H]-UDP-galactose, and 1040 pi
of water. —4— Represents the specific activity of normal plasma
membrane gaiTase. —Tl— Represents the specific activity of lactating
plasma membrane GaiTase
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Figure 11. Cumulative Average Concentrations of Plasma Membrane-Associated
Galactosyltransferase(s).
The assay mixture consisted of: 200 |4l sodium cacodylate, 200 |Lil
ovomucoid, 6 |a,l P-mercaptoethanol, 40 |a.l UDP-galactose, 40 ml Triton
X-100, 20 ii\ ATP, 40 pi MnCb, 10 |il [^H]-UDP-galactose, and 1040 pi
of water.
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30 Minute Overall Incubation Period
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Western Blot Analysis of Plasma Membrame-Associated Galactosvltransferase
The data presented in figure 12 confirms the immunoreactivity of
galactosyltransferase antibodies. The antibody recognized and associated with three
galactosyltransferase species, two of which had estimated molecular weights of 90,000
and 82,000 daltons, and the third species 70,000 daltons.
Western-Blot analysis was performed on the fractions designated F2 (from both
normal and lactating mammary tissue) that were taken from the sucrose density gradient
(Figure 7). Figure 13 illustrate the cross-reactivity of plasma membrane-associated
galactosyltransferase(s) with the antibody that was prepared against bovine milk
galactosyltransferase. The banding patterns as well as the relative molecular weights of
the GalTase entities, that are associated with the plasma membranes of both normal and
physiologically altered (lactating) mammary gland tissues, were delineated. The isolates
exhibited major species that had an estimated molecular weight of 90,000 daltons
corresponding to the “long” form of GalTase, and a minor species that had an estimated




Figure 12. Immunohistochemical demonstration of bovine milk
galactosyltransferase(s).
Approximately 10 pg of protein were loaded onto a 10% SDS gel. The
proteins were then transferred onto a nitrocellulose membrane, and
incubated with an anti-galactosyltransferase antibody.
Lane 1 Molecular weight markers (myosin, 209,000 daltons;
beta-galactosidase, 130,000 daltons; bovine serum albumin
85,000 daltons; carbonic anhydrase 43,000 daltons;
soybean trypsin inhibitor 32,000 daltons).






Figure 13. Western Blot Analysis of Plasma membrane-associated
galactosyltransferase(s).
Lane 1 Molecular weight markers (myosin, 209,000 daltons;
beta-galactosidase, 130,000 daltons; bovine serum albumin
85,000 daltons; carbonic anhydrase 43,000 daltons;
soybean trypsin inhibitor 32,000 daltons).
Lane 2 Normal mammary gland plasma membrane GalTase





The plasma membrane plays a very important regulatory role in cellular
metabolism and function. Classical methods of isolation of plasma membranes originally
developed by Neville (1960) and later modified by Emmelot et al. (1962, 1966, 1966)
made it possible to study the biochemical properties of this particular cellular organelle
(Ray, 1970). The methods developed by these researchers gave a low yield of
membranes, prompting other researchers to develop methods of isolation which increased
the total yield of plasma membranes and retained the activities of functional enzymes.
In this study, a modified method of Ray (1970) and Femandez-Briera et al. (1989)
was employed to obtain mammary gland plasma membrane rich fractions (Figure 7) with
minimal cross contamination with other cellular organelles isolated from Long Evans rats
(Figure 6). Female Long Evans, rats averaging approximately 300 gm, were sacrificed
and the mammary gland tissues were excised, and placed in liquid nitrogen until further
processing. The tissues were thawed, weighed and subjected to differential
centrifugation procedures to obtain plasma membranes. Comparative studies were
conducted on plasma membranes from both normal (non-lactating) and physiologically
altered (lactating) mammary gland tissues. In these studies, physiologically altered
(lactating) tissue was utilized in view of its unique characteristics. This particular tissue
follows a pattern of metabolic amplification (approximately 200 fold increase in
epithelial cells) which mammary tumors mimic during the carcinogenesis process. This
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metabolic amplification is strictly dictated by the presence of a variety of hormones,
including the sex steroids, prolactin, oxytocin, cortisol, thyroid hormone, and growth
hormone (Bland and Copeland, 1991). At the completion of the process of lactogenesis,
the complex neuroendocrine feedback system (which controls milk synthesis, ejection
and maintains lactation) shuts down. Upon doing so, the cells of the mammary gland
begin to involute and gradually return to the resting state. This step does not occur in
mammary tumor cells.
The purity of the isolated plasma membrane fractions was assessed via the
measurements of specific enzymatic activities. The following marker enzymes were
utilized to assess the purity and enrichment of the plasma membranes: alkaline
p-nitrophenyl phosphatase as a plasma membrane marker enzyme, and succinate
dehydrogenase as an inner mitochondrial membrane marker enzyme. In this research, it
was observed that the plasma membrane isolates showed a relatively high alkaline
p-nitrophenyl phosphatase activity (Figure 8) in both the normal and physiologically
altered (lactating) plasma membrane fractions, and a relatively low succinate
dehydrogenase activity (Figure 9) as compared to the results presented by Femandez-
Briera et al (1989). The normal mammary gland fraction was found to have alkaline p-
nitrophenyl phosphatase activity of 1.833 Abs units/min and the lactating had an activity
of 1.895 Abs/min (Figure 8). The succinate dehydrogenase assay was used in this study
as a tool to assess exactly how much of the plasma membrane fraction was contaminated
with mitochondrial membranes. These results demonstrated that there was minimal
contamination of the fraction. It was also found that both the normal and lactating
fraction contained low levels of mitochondrial membranes. Figure 9 shows that the
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normal membrane fraction had an activity of 0.094 Abs/min and the lactating had an
activity of 0.027 Abs/min.
Characterization of the plasma membrane-associated galactosyltransferase(s)
requires that a plasma membrane fraction relatively free of contaminants be isolated. The
aforementioned assays have demonstrated that the modified methods of Ray (1970) and
Femandez-Briera et al. (1989) utilized in this study were effective in isolating plasma
membrane fractions with minimal levels of cross contamination with other cellular
organelles, specifically mitochondrial membranes, which have similar densities as the
plasma membrane.
The data presented in figure 10 demonstrates that galactosyltransferase is indeed
localized on the plasma membranes of Long Evans rats mammary gland tissues and is
enzymatically active. The plasma membrane-associated GalTase(s) catalyzed the transfer
of UDP-[^H]-galactose to the endogenous acceptor protein ovomucoid. These studies
report that the reaction activity was greatly reduced for the lactating plasma membrane
GalTase(s) verses that of the normal, even though there was significantly more GalTase
present in this tissue type.
To ascertain the immunoreactivity of the galactosyltransferase antibody, which
was raised against purified bovine milk galactosyltransferase(s), approximately 10 pg of
purified proteins were separated via sodium dodecyl-sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). After separation the proteins were then subjected to
immunoblotting procedures. Figure 12 confirms that the antibody was indeed
immunoreactive to the antigen from which it was synthesized.
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The anti-galactosyltransferase antibody recognized two major species of approximately
90,000 and 82,000 daltons, as well as one minor species of approximately 70,000 daltons.
The three species that were identified are consistent with results presented by Powell and
Brew (1974).
Figure 13 shows the cross-reactivity of plasma membrane-associated
galactosyltransferase proteins to the bovine milk galactosyltransferase antibody.
Immediately following separation on an SDS-PAGE gel, the plasma membrane isolates
were subjected to immunoblotting to ascertain the homology between plasma membrane
reactive GalTase proteins and the bovine milk proteins. As shown in figure 13, two
forms of galactosyltransferase were found to be associated with the plasma membrane, a
“short” form and a “long” form. Previously published data shows that the molecular
weight values for GalTases range from 29,000 to 130,000 daltons (Magee et al., 1973,
Strous et al., 1988, Barker et al, 1972, Lopez et al, 1991, Russo et al, 1992, and Teasdale
et al, 1992).
These studies revealed that the normal and lactating plasma membrane isolates
exhibited major species with estimated molecular weights of 90,000 daltons
corresponding to the “long” form of GalTase and a minor species that had an estimated
molecular weight of 70,000 daltons (Figure 13) corresponding to the “short’ form of
GalTase. Strous et al (1988) have shown that GalTase is synthesized as two precursor
polypeptides with molecular weights of 45,000 and 47,000 daltons and that the enzyme is
present in the Golgi as a mature glycoprotein with a molecular weight value of 54,000.
This data did not indicate a specific value for plasma membrane GalTase. Data obtained
in this particular study demonstrated that there was an increase in the concentration of the
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“long” form of plasma membrane-associated GalTase(s) in the lactating mammary gland
tissue. This increased concentration can be determined by observing the increased
intensity of the band in lane 4 of figure 12 as compared to the same band in lane 3 of
figure 12. This increase in plasma membrane-associated galactosyltransferase can be
attributed to the physiological state of the lactating mammary gland tissue. This
particular tissue responded to hormonal stimuli, which resulted in developmental changes
that modified both the architecture and biological characteristics of the gland which lead
to cellular proliferation and differentiation.
The results generated from these studies indicate that the techniques utilized were
effective in validating that galactosyltransferase is indeed associated with the mammary
gland plasma membranes of Long Evans rats. Therefore, these techniques and the insight
gained from conducting these experiments can be utilized to delineate the role that
plasma membrane-associated GalTase(s) play in cellular proliferation during the
carcinogenesis process. Furthermore, these results support the contention that the rat
mammary gland is a good model for studying tumorigenesis at the level of early
detection. The studies reported show that cell-cell interaction is initiated at the molecular
level prior to any visible structural cell-cell contact.
CHAPTER VI
CONCLUSIONS
This investigation involved the isolation and biochemical characterization of both normal
and physiologically altered (lactating) plasma membrane-associated
galactosyltransferases. The data obtained are of considerable interest and the following
conclusions can be stated;
1. Original cellular fractionation protocols were utilized in this research to yield plasma
membrane enriched fractions, the purity of which were ascertained via alkaline
p-nitrophenyl phosphatase and succinate dehydrogenase marker enzyme assays.
2. The enzymatic activity of the plasma membrane-associated GalTase(s) was
determined via the galactosyltransferase assay. It was shown that the normal plasma
membrane-associated GalTase(s) had a higher specific activity for the transfer of
[^H]-UDP-galactose onto the protein ovomucoid than that of the physiologically
altered (lactating) GalTase.
3. The relative concentrations of galactosyltransferase(s) were obtained for both tissue
types.
4. Western blot analysis demonstrated the existence and relative molecular weights of
plasma membrane-associated galactosyltransferase(s) in both normal and
physiologically altered (lactating) mammary gland tissues. The regulatory role of this
enzyme in cell membrane surface interactions has been speculated. The data in this
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study suggest that a functional directive for this enzyme as a plasma membrane domain
centers on its regulatory role in cell-cell contact or cell-cell inhibition, which when absent
may lead to cell proliferation.
REFERENCES
Akimoto Y, Obinata A, Endo H., Furukawa K, Aoki D, Nozawa S, and Hirano H. 1995.
Immunocytochemical localization of the protein reactive to human beta-1,
4-galactosyltransferase antibodies during chick embryonic skin differentiation.
Anat. Rec. 243(1): 109-119.
Appedu PA and Shur BD. 1994. Molecular analysis of cell surface beta-1,
4-galactosyltransferase function during cell migration. Proc. Natl. Acad. Sci.
91(6): 2095-2099.
Barcellos- Hoff MH. 1992. Mammary epithelial recognition on extracellular matrix is
mediated by cell surface galactosyltransferase. Experimental Cell Research 201:
225-234.
Barker R, Olsen WO, Shaper N L, and Hill R. 1972. Agarose derivatives of the uridine
2-diphosphate and N-acetylglucosamine in the purification of a
galactosyltransferase. J. Biol. Chem. 247: 7135-7147.
Bayna EM, Runyan RB, Scully NF, Reichner J, Lopez LC, and Shur BD. 1986. Cell
surface galactosyltransferase as a recognition molecule during development. Mol.
Cell Biochem. 72(1-2): 141-151.
Bayna EM, Shaper JH, and Shur BD. 1988. Temporally specific involvement of cell
surface Beta-1, 4-galactosyltransferase during mouse embryo morula compaction.
Cell 53: 145-157.
Bland KI, Copland III, EM, editors 1991. The Breast: Comprehensive management of
benign and malignant diseases. 3'^'^ ed. Phildelphia: W. B. Saunders Company. 36
P-
Blobel G, and Dobberstein B. 1975. Transfer of proteins across membranes. J. Cell Biol.
67: 835-840.
Brew K, Vanaman TC, and Hill R.L. 1967. The role of a-lactalbumin and A protein in
lactose synthetase: A unique mechanism for the control of a biological reaction.
Proc. Natl. Acad. Sci. 59: 491-497.
Brodbeck U, Denton WL, Tanahashi N, and Ebner KE. 1967. The isolation and




Browne JM, George-Taylor M, and Brown IV. 1997. Galactosyltransferase: A mammary
gland plasma membrane-associated enzyme with different functions in normal
and neoplastic tissues. Nature Biotechnology 8: 7-9.
Garden R. 1977. Smooth endoplasmic reticulum in rat hepatocytes during glycogen
deposition and depletion. Int. Rev. Cytol. 48: 221-226.
Cunningham W. 1971. Isolation of germ cell Golgi apparatus from seminiferous tubules
of rat testes. J. Cell Biol. 51: 273-285.
Depierre J, and Dallner G. 1975. Structural aspects of the membrane of the endoplasmic
reticulum. Biophys. Acta. 415: 411-425.
Emmelot P, and Bos CJ. 1962. A stimulatory effect of potassium cyanide on the
glycerolphosphate dehydrogenase of normal and neoplastic tissues. Biochim.
Biophys. Acta. 59: 496-497.
Emmelot P, and Bos CJ. 1966. Studies on plasma membranes. II. K'^-Dependent
p-nitrophenyl phosphatase activity of plasma membranes isolated from rat liver.
Biochim. Biophys. Acta. 121: 375-85.
Emmelot P, and Bos CJ. 1966. Studies on plasma membranes. III. Mg^'^-ATPase,
(Na'*'-K'^-Mg^'^)-ATPase and 5’-Nucleotidase activity of plasma membranes
isolated from rat liver. Biochim. Biophys. Acta. 120: 369-371.
Evans S, Lopez L, and Shur BD. 1993. Dominant negative mutation in cell surface beta
1,4-galactosyltransferase inhibits cell-cell and cell matrix interactions. J. of Cell
Biology. 120:1045-1057.
Farquar MG. 1985. Progress in unraveling pathways of Golgi Traffic. Ann. Rev. Cell
Biol. 1: 447-488.
Fitzgerald DK, Colvin B, Mawal R, and Ebner KE. 1970. Enzymatic assay for
galactosyltransferase activity of lactose synthetase and a-lactalbumin in purified
and crude systems. Analytical Biochem. 36: 43-61.
Femandez-Briera A, Louisot P, and Morrelis R. 1989. Purification of liver plasma
membranes and localization of a protein galactosyltransferase. Archives
Internationales de Physiologie et de Biochemie. 97: 221-230.
Fleischer S. 1983. Biomembranes. Methods In Enzymology. General methods for the
preparation of plasma membranes. 96: 45-175.
Furukawa K, Sato T. 1999. (3-1,4-Galactosyltransferase of V-glycan is a complex
process. Biochem et Biophysica Acta. 1473: 54-66.
62
George-Taylor, M. (1994). Isolation, purification, and characterization of
Pl,4-galactosyltransferase from rat mammary tissue, [dissertation]. Atlanta (GA):
Clark Atlanta University. 81 p.
Gong X, Dubois DH, Miller DJ, and Shur BD. 1995. Activation of a G protein complex
by aggregation of beta-1, 4-gaIactosyltransferase on the surface of sperm.
Science 269: 1718-1721.
Goudsmith EM, Ketchum PA, Grossen MK, and Blake DA. 1989. Biosynthesis of
galactogen: identification of (l-6)-D-galactosyltransferase in Helix pomantia
albumin glands. Biochimica et Biophysica Acta 992: 289-297.
Hinton D. 1995. Altering the expression of cell surface B 1,4-Galactosyltransferase
modulates cell growth. Experimental Cell Research 219: 640-649.
Hirohashi N. 1998. Sperm-egg binding in the sea urchin: a high level of intracellular
ATP stabilizes sperm attachment to the egg receptor. Dev. Biol. 201(2): 270-279.
Hirohashi N. 1998. The 350-kda sea urchin egg receptor for sperm is localized in the
vitelline layer. Dev. Biol. 204(1): 305-315.
Huszar G, Sbracia M, Vigue L, Miller DJ, Shur BD. 1997. Sperm plasma membrane
remodeling during spermatogenetic maturation in men: relationship among
plasma membrane beta 1,4-galactosyltransferase, cytoplasmic creatine
phosphokinase, and creatine phosphokinase isoform ratios. Biol Reprod. 56:
1020-1024.
Johnson FM, and Shur BD. 1999. The level of cell surface P 1,4-galactosyltransferase I
influences the invasive potential of murine melanoma cells. J. of Cell Science
112: 2785-2795.
Joziasse DH, Shaper NL, Kim D, Van den Ejinden DH. 1992. Murine 1,3
galactosyltransferase. A single gene locus specifies four isoforms of the enzyme
by alternate splicing. J. Biol. Chem. 267: 5534-5541.
Just ML. 1997. Reexamination of the sequence of the sea urchin egg receptor for sperm:
implications with respect to its properties. Dev. Biol. 184(1): 25-30.
Kitazume-Kawaguchi S. 1997. Identification of sulfated oligosialic acid units in the
0-linked glycan of the sea urchin egg receptor for sperm. Proc. Natl. Acad. Sci.
94(8): 3650-3655.
Laemmli UK. 1970. Cleavage of structural proteins during assembly of the head of the
bacteriophage T4. Nature 227: 680-685.
63
Larson JL, and Miller DJ. 1997. Sperm from a variety of mammalian species express
betal, 4-galactosyltransferase on their surface. Biol. Reprod. 57(2): 442-453.
Lawrence RA, editor 1985. Breastfeeding: A Guide for the Medical Profession. 2"^* ed.
St. Louis: The C. V. Mosby Company. 63 p.
Lennarz W J, 1975. Sugars in glycoprotein synthesis. Science 188: 986-997.
Lopez LC, and Shur BD. 1988. Comparison of two independent cDNA clones reported
to encoded bl,4-galactosyltransferase. Biochemical and Biophysical Research
Communications 156: 1223-1229.
Lopez LC, and Shur BD. 1987. Redistribution of mouse sperm surface
galactosyltransferase after acrosome reaction. J. Cell Biol. 105: 1663-1670.
Lopez LC. 1985. Receptor function of mouse sperm surface galactosyltransferase during
fertilization. J. Cell Biol. 101: 1510-1521.
Lopez LC, Youakim A, Evans SC, and Shur BD. 1991. Evidence for a molecular
distinction between Golgi and Cell surface forms of beta1.4-galactosyltransferase. J. Biol. Chem. 266: 15984-15991.
Lu Q, and Shur BD. 1997. Sperm from beta 1,4-galactosyltransferase-null mice are
refractory to ZP3-induced acrosome reactions and penetrate the zona pellucida
pooly. Development 124: 4121-4131.
Magee S, and Ebner K. 1973. Origin of multiple forms of the galactosyltransferase of the
lactose synthetase system. Fed. Proc. 32: 541.
Masri KA, Appert HE, Fukuda MN. 1988. Identification of the full-length coding
sequence for human galactosyltransferase (beta-N-acetylglucosaminide: beta1.4-galactosyltransferase). Biochem Biophys Res Commun. 157(2): 657-663.
Mengle-Gaw L, McCoy- Haman MF, and Tiemeier DC. 1991. Genomic structure and
expression of human P-l,4-galatosyltransferase. Biochem. Biophys. Res. Comm.
176: 1269-1276.
Mitchell GW, and Bassett LW, editors. 1990. The Female Breast and its Disorders.
Baltimore: Williams and Wilkins. 44p.
Molnar J, 1975. A proposed pathway of plasma glycoprotein synthesis. Mol. Cell.
Biochem. 6: 3-9.
Morre‘ DJ, Kartenbeck J, and Franke WW. 1979. Membrane flow and interconversions
among endomembranes. Biochimica et Biophysica Acta 559: 71-152.
64
Neville DM, 1960. The isolation of a cell membrane fraction from rat liver. J. Biophys.
Biochem. Cytol. 8: 413-420.
Nguyen TM, 1994. Expressing murine (31,4-galactosyltransferase in HeLa cells produces
a cell surface galactosyltransferase-dependent phenotype. The Journal of
Biological Chemistry. 269: 28000-28009.
Nilsson T. 1991. The membrane spanning domain of pi,4-galactosyltransferase specifies
trans Golgi localization. EMBO Journal. 10: 3567-3575.
Parodi A, and Leloir L. 1976. Lipid intermediates in protein glycosylation. Trends
Biochem. Sci. 1(3): 58-62.
Pelham HRB. 1989. Control of protein exit from the endoplasmic reticulum. Ann. Rev.
Cell Biol. 5: 1-23.
Penno MB, Passaniti AF, Fridman RH, Jordan GW, Kumar S, and Scott AF. 1989. In
vitro galactosylation of a 110 kda glycoprotein by an endogenous cell surface
galactosyltransferase correlates with the invasiveness of adrenal carcinoma cells.
Proc. Natl. Acad. Sci. 86: 6075-6061.
Pestalozzi DM, Hess M, and Berger EG. 1982. Immunohistochemical evidence for cell
surface and Glogi localization of galactosyltransferase in human stomach,
jejunum, liver and pancreas. J. Histochem. Cytochem. 30(11): 1146-1152.
Powell JT and Brew K. 1974. The preparation and characterization of two forms of
bovine galactosyltransferase. Eur. J. Biochem. 48: 217-228.
Pratt SA, Scully NF, Shur BD. 1993. Cell surface beta 1,4 galactosyltransferase on
primary spermatocytes facilitates their initial adhesion to Sertoli cells in vitro.
Biol. Reprod. 49(3): 470-482.
Pryer NK, Wuestehube LJ, and Schekam R. 1992. Vesicle-mediated protein sorting.
Ann. Rev. Biochem. 61: 471-516.
Rajput B, Shaper NL, and Shaper JH. 1996. Transcriptional regulation of murine beta
1,4 galactosyltransferase in somatic cells. Analysis of a gene that serves both a
housekeeping and mammary gland specific function. J. Biol. Chem. 271: 5131-
5142.
Ray TK, 1970. A modified method for the isolation of the plasma membrane from rat
liver. Biochim. Biophy. Acta. 196: 1-9.
Riordan J, and Auerbach KG, editors. 1993. Breastfeeding and Human Lactation. Boston:
Jones and Bartlett Publishers. 103p.
65
Rose JK, and Dorns RW. 1988. Regulation of protein export from the endoplasmic
reticulum. Ann. Rev. Cell Biol. 4: 257-288.
Roseman S. 1970. The synthesis of complex carbohydrates by multiglytransferase
system and their potential function in intracellular adhesion. Chem. Phys. Lipids
5: 270-297.
Roth J, Lentze MJ, and Berger EG. 1985. Immunocytochemical demonstration of
ectoglactosyltransferase in adsorptive intestinal cells. J. Cell Biol. 100: 118-125.
Rothman JE. 1994. Mechanisms of intracellular protein transport. Nature 372: 55-63.
Rothman JE, and Orci L. 1992. Molecular dissection of the secretory pathway. Nature
355: 409-415.
Russo R, and Shaper N. 1990. Bovine B 1,4-galactosyltransferase: Two sets of mRNA
transcripts encode two forms of the protein with different amino-terminal
domains. J. Biol. Chem. 265: 3324-3331.
Russo R, and Shaper N. 1992. pi, 4-galactosyltransferase: A short NH2-terminal
fragment that includes the cytoplasmic and transmembrane domain is sufficient
for Golgi retention. J. Biol. Chem. 267: 9241-9247.
Schachter H, and Roseman S, editors. 1980. The biochemistry of Glycoproteins and
proteoglycaans^ New York: Plenum Press. 89p.
Schachter H, Jabbal I, Hudgin RL, and Pinteric L. 1970. Intercellular
localization of liver nucleotide glycoprotein glycosyltransferases in Golgi rich
fraction. J. Biol. Chem. 245: 1090-1100.
Shaper NL, Mann PL, and Shaper JH. 1985. Cell surface galactosyltransferase:
immunochemical localization. J. Cell Biochem. 28: 229-239.
Shaper N, Wright WW, and Shaper JH. 1990. Murine P 1,4-galactosyltransferase: Both
amounts and structure of the mRNA are regulated during spermatogenesis. Proc.
Natl. Acad. Sci. 87: 791-795.
Shur BD, Evans S, and Lu Q. 1998. Cell surface galactosyltransferase: current issues.
Glycoconjugate Journal 15: 537-548.
Shur, B. D. (1988). The molecular biology of fertilization. New York: Academic Press.
Shur BD, 1993. Glycosyltransferase as cell adhesion molecules. Current Opinion in Cell
Biology. 5: 854-863.
66
Shur BD. 1982. Cell surface glycosyltransferase activities during normal and mutant
(T/T) mesenchyme migration. Dev. Biol. 91: 149-162.
Strous GJ, and Berger EG. 1982. Biosynthesis, intracellular transport, and release of the
Golgi enzyme galactosyltransferase (Lactose synthetase A protein) in HeLa cells.
J. Biol. Chem. 257:7623-7628.
Strous GJ, and Schachter H. 1986. Golgi and secreted galactosyltransferase. CRC.
Critical Reviews in Biochemistry 21:119-151
Strous GJ, Van Kerkhof P, Willemsen R, Geuze H.J, and Berger EG. 1983. Transport and
topology of galactosyltransferase in endomembranes of HeLa Cells. J. Cell Biol.
97(3): 723-727.
Strous GJ, Van Kerkhof P, and Berger EG. 1988. In vitro biosynthesis of two human
galactosyltransferase polypeptides. Biochem. Biophy. Comm. 151: 314-319.
Teasdale RD, D‘Agastro G, and Gleeson PA. 1992. The signal for golgi retention of
bovine P1,4-galactosyltransferase is in the transmembrane domain. J. Biol. Chem.
267: 4084-4096.
Tian J. 1999. Xenopus laevis sperm receptor gp69/64 glycoprotein is a homologue of the
mammalian sperm receptor ZP2. Proc. Natl. Acad. Sci. 96(3): 829-834.
Tian J. 1997. Gamete interaction in Xenopus laevis: Identification of sperm binding
glycoproteins in the egg vitelline envelope. J. Cell Biol. 136(5): 1099-108.
Trayler IP, and Hill R. 1971. The purification and properties of the A protein of lactose
synthetase. J. Biol. Chem. 246: 6666-6675.
van Die I, Van Tetering A, Schiphorst W, Sato T, Furukawa K, and van den Eijnden D.
1999. The acceptor substrate specificity of human P4-galactosyltransferase V
indicates its potential function in O-glycosylation. FEBS Letters. 450: 52-56.
Youakim A, Dubois DH, Shur BD. 1994. Localization of the long form of
beta-l,4-galactosyltransferase to the plasma membrane and Golgi complex of 3T3
and F9 cells by immunofluorescence confocal microscopy. Proc. Natl. Acad. Sci.
91(23): 10913-10917.
Zhou D, Chen C, Jiang S, Shen Z, Chi Z, Gu J. 1998. Expression of
pl,4-galactosyltransferase in the development of mouse brain. Biochimicia et
Biophysica Acta 1425: 204-208.
